HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael A Brehm Selected Research
Michael A Brehm Research Topics
Disease
18
Infections
01/2023 - 07/2002
15
Neoplasms (Cancer)
11/2023 - 07/2012
7
Virus Diseases (Viral Diseases)
12/2016 - 07/2002
6
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022 - 01/2009
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
03/2024 - 02/2014
4
Inflammation (Inflammations)
01/2023 - 11/2017
3
Fibrosis (Cirrhosis)
01/2023 - 11/2017
3
Leukemia
01/2021 - 02/2014
2
Typhoid Fever (Typhoid)
03/2024 - 08/2010
2
Breast Neoplasms (Breast Cancer)
11/2023 - 08/2023
2
Triple Negative Breast Neoplasms
11/2023 - 01/2018
2
Necrosis
01/2023 - 09/2006
2
Cytokine Release Syndrome
01/2023 - 01/2020
2
Bites and Stings (Sting)
01/2023 - 01/2020
2
Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2020
2
Obesity
01/2022 - 03/2016
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 04/2014
2
Hypersensitivity (Allergy)
01/2020 - 01/2016
2
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2019 - 07/2012
2
Anaphylaxis (Anaphylactic Shock)
01/2019 - 01/2016
1
Brain Neoplasms (Brain Tumor)
08/2023
1
Melanoma (Melanoma, Malignant)
08/2023
1
Neoplasm Metastasis (Metastasis)
08/2023
1
Burkitt Lymphoma (Burkitt's Lymphoma)
01/2023
1
Foreign Bodies (Foreign Body)
01/2023
1
Prostatic Neoplasms (Prostate Cancer)
01/2023
1
Endometrial Neoplasms (Endometrial Cancer)
01/2023
1
Liver Diseases (Liver Disease)
01/2022
1
Non-alcoholic Fatty Liver Disease
01/2022
1
Fatty Liver
01/2022
1
Liver Cirrhosis (Hepatic Cirrhosis)
01/2020
1
Cytopenia
01/2020
1
Fever (Fevers)
01/2020
1
Immune System Diseases (Immune Disorders)
01/2019
1
Urinary Bladder Neoplasms (Bladder Cancer)
01/2018
1
Sarcoma (Soft Tissue Sarcoma)
01/2018
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1
Lymphoma (Lymphomas)
01/2017
1
Splenomegaly
10/2016
Drug/Important Bio-Agent (IBA)
9
Proteins (Proteins, Gene)
FDA Link
01/2023 - 10/2004
8
Cytokines
IBA
08/2023 - 02/2006
6
Epitopes
IBA
05/2010 - 07/2002
5
Antigens
IBA
01/2022 - 06/2006
4
Phosphotransferases (Kinase)
IBA
01/2019 - 02/2006
3
Monoclonal Antibodies
IBA
01/2023 - 01/2017
3
Insulin (Novolin)
FDA Link
01/2022 - 04/2015
3
Small Interfering RNA (siRNA)
IBA
01/2021 - 01/2009
3
Vaccines
IBA
12/2013 - 05/2010
2
Programmed Cell Death 1 Receptor
IBA
01/2024 - 01/2018
2
Calcium
IBA
11/2023 - 02/2006
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
08/2023 - 06/2006
2
Immune Checkpoint Inhibitors
IBA
08/2023 - 01/2023
2
Rituximab (Mabthera)
FDA Link
01/2023 - 01/2017
2
Antibodies
IBA
01/2023 - 01/2015
2
Immunoglobulin G (IgG)
IBA
01/2023 - 12/2016
2
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2018 - 12/2013
2
Complement System Proteins (Complement)
IBA
01/2017 - 01/2007
2
Immunoglobulin M (IgM)
IBA
12/2016 - 01/2015
1
Virulence Factors (Pathogenicity Factors)
IBA
03/2024
1
Integrins
IBA
11/2023
1
TRPC6 Cation Channel
IBA
11/2023
1
Transient Receptor Potential Channels
IBA
11/2023
1
Messenger RNA (mRNA)
IBA
11/2023
1
abemaciclib
IBA
08/2023
1
Amphiregulin
IBA
01/2023
1
Toll-Like Receptor Agonists
IBA
01/2023
1
Biocompatible Materials (Biomaterials)
IBA
01/2023
1
Androgen Receptors (Androgen Receptor)
IBA
01/2023
1
Interleukin-6 (Interleukin 6)
IBA
01/2023
1
Neuropilin-2
IBA
01/2023
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2023
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2023
1
B7-H1 Antigen
IBA
01/2023
1
Diglycerides
IBA
01/2022
1
Triglycerides (Triacylglycerol)
IBA
01/2022
1
Glucocorticoids
IBA
01/2021
1
Prostaglandins
IBA
01/2021
1
Indicators and Reagents (Reagents)
IBA
01/2021
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2021
1
Dinoprostone (PGE2)
FDA Link
01/2021
1
Viral Proteins
IBA
02/2020
1
NF-kappa B (NF-kB)
IBA
02/2020
1
Interferon Type I
IBA
02/2020
1
deoxyribonuclease II (DNASE II)
IBA
01/2020
1
Genetic Markers (Genetic Marker)
IBA
01/2019
1
Immunoglobulins (Immunoglobulin)
IBA
01/2019
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2019
1
AK002
IBA
01/2019
1
N-Acetylneuraminic Acid (Sialic Acid)
IBA
01/2019
1
pembrolizumab
IBA
01/2018
1
Globins
IBA
10/2016
Therapy/Procedure
11
Therapeutics
03/2024 - 05/2012
4
Immunotherapy
01/2023 - 01/2018
2
Drug Therapy (Chemotherapy)
11/2023 - 02/2014
2
Transplantation
01/2020 - 01/2019
1
Aftercare (After-Treatment)
01/2023
1
Castration
01/2023
1
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023
1
RNAi Therapeutics
01/2022
1
Precision Medicine
01/2019